MOHAMMED MOUGHRABI: Open Payments
NPI 1831452986 · PATERSON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,722 in 32 payments from 11 companies in 2025. Trend: 2023 $1,301 · 2024 $1,344 · 2025 $2,722
Food & beverage: $2,722
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 10 | $1,028 |
| AstraZeneca Pharmaceuticals LP | 7 | $341 |
| Corcept Therapeutics | 2 | $268 |
| ABBVIE INC. | 2 | $250 |
| Amgen Inc. | 5 | $248 |
| Penumbra, Inc. | 1 | $126 |
| Novo Nordisk Inc | 1 | $125 |
| ABIOMED | 1 | $123 |
| Braeburn Inc. | 1 | $122 |
| Bard Peripheral Vascular, Inc. | 1 | $77 |
Products named: REZDIFFRA, Korlym, MAVYRET, AIRSUPRA, REPATHA, Indigo System, BREZTRI, Ozempic.
Industry payments across NJ — which companies pay providers there.
